Vikram Deshpande, a Professor of Pathology at Harvard Medical School, reflects on his journey from India, highlighting the disparities in healthcare access between high-income countries (HICs) and low- to middle-income countries (LMICs). He critiques the WHO Classification of Tumors for its lack of accessibility to LMICs, proposing a dual editorial policy and emphasizing the necessity of incorporating local expertise into global health guidelines. By fostering equity and trust, Deshpande advocates for a more inclusive approach to pathological standards.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.